+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 65Years
All Genders
ID06550622

Study of Improved Detection of Serum HBsAg and Reversion Rates in Adults With Chronic Hepatitis B After Functional Cure

Led by Huashan Hospital · Updated on 2024-08-13

300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand the rate at which hepatitis B surface antigen HBsAg returns in chronic hepatitis B patients who have tested negative for HBsAg after treatment. The study compares a new, more sensitive HBsAg NEXT assay with the current ARCHITECT HBsAg assay to measure HBsAg reversion at 48 weeks after stopping treatment. It focuses on patients who have achieved functional cure under interferon therapy and completed consolidation therapy.

CONDITIONS

Brief Title

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

Research Team

F

Fahong Li

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here